1. Home
  2. FRT vs RGEN Comparison

FRT vs RGEN Comparison

Compare FRT & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Federal Realty Investment Trust

FRT

Federal Realty Investment Trust

HOLD

Current Price

$101.57

Market Cap

8.4B

Sector

Real Estate

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$162.25

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRT
RGEN
Founded
1962
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FRT
RGEN
Price
$101.57
$162.25
Analyst Decision
Buy
Buy
Analyst Count
14
10
Target Price
$110.21
$174.90
AVG Volume (30 Days)
691.3K
701.7K
Earning Date
10-31-2025
10-28-2025
Dividend Yield
4.46%
N/A
EPS Growth
14.84
N/A
EPS
3.95
0.03
Revenue
$1,257,396,000.00
$707,890,000.00
Revenue This Year
$5.51
$17.84
Revenue Next Year
$5.27
$12.57
P/E Ratio
$25.69
$5,259.20
Revenue Growth
6.11
11.74
52 Week Low
$80.65
$102.97
52 Week High
$113.13
$182.52

Technical Indicators

Market Signals
Indicator
FRT
RGEN
Relative Strength Index (RSI) 63.79 54.15
Support Level $100.00 $156.01
Resistance Level $102.81 $165.02
Average True Range (ATR) 1.45 4.65
MACD 0.48 -1.07
Stochastic Oscillator 83.12 43.33

Price Performance

Historical Comparison
FRT
RGEN

About FRT Federal Realty Investment Trust

Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 27.4 million square feet of retail space and 3,000 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: